abstract |
The present invention relates to a novel series of analogs of glucose-dependent insulinotropic polypeptide compounds, pharmaceutical compositions comprising such compounds, and GIP-receptors for the treatment of GIP-receptor mediated conditions such as non-insulin dependent diabetes mellitus and obesity ≪ / RTI > the use of such compounds as agonists or antagonists. |